outpatient intervention performed in a procedure similar to gastroscopy, without requiring implants or long-term medication use.

Sedivention’s platform includes proprietary cryo-balloon catheter technology and related medical devices for interventional obesity care. The company conducts product development, preclinical validation, and clinical preparation activities focused on gastrointestinal and metabolic health applications. Its technology is designed to support obesity management by addressing physiological mechanisms related to hunger and satiety regulation.